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krege_The purpose of this analysis was to assess the association of osteoporosis-related vertebral fracture burden and
pulmonary function. This study also examined the relationship between vertebral fracture burden and height loss,
estimated by arm span  height. This was a single-site and single-visit study. Patients had a history of at least 1
moderate or severe vertebral fracture. Vertebral fracture burden was quantified using the spinal deformity index
(SDI). Pulmonary function during inspiration was determined by spirometry. Forty-one women aged 70e91
completed the study. Vertebral fracture burden negatively correlated with forced inspiratory vital capacity and inspi-
ratory time. For each unit increase in SDI, forced inspiratory vital capacity decreased by 1.62%, and inspiratory time
decreased by 2.39%. There was no correlation between SDI and measures of inspiratory flow. For each unit increase
in SDI, height decreased by about 0.5 cm. Vertebral fractures were associated with decreased lung volume and
height loss.
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Vertebral fractures are common among people with osteo-
porosis. In the year 2000, there were an estimated 1.4 million
osteoporosis-related vertebral fractures worldwide (1). Indi-
viduals with a vertebral fracture have an increased risk of
future vertebral fractures and other types of fractures (2,3).
Vertebral fracture risk is also increased among patients with
chronic obstructive pulmonary disorder (COPD), attributed
to their risk for osteoporosis brought on by numerous factors,
including glucocorticoid treatment, smoking, and physical
inactivity (4e8). Most guidelines, including International So-
ciety for Clinical Densitometry positions, emphasize the
importance of vertebral fractures in the identification ofceived 10/27/14; Revised 02/04/15; Accepted 02/09/15.
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506patients requiring pharmacotherapy. In addition, the combina-
tion of vertebral fractures and osteoporosis is associated with
increased morbidity and mortality (7,9e11).
This single-visit study was originally conducted to
compare 2 inhalation devices for potential use by elderly
women with osteoporosis and a history of at least 1 moderate
or severe vertebral fracture. Patients also had pulmonary func-
tion testing without in line inhalers, and these are the data re-
ported here. Study measures included quantification of
vertebral fracture burden using the spinal deformity index
(SDI) (12,13), height, arm span, and pulmonary function dur-
ing inspiration by spirometry. The purpose of this post hoc
analysis is to assess the association of osteoporosis-related
vertebral fracture burden and pulmonary function and to
examine the relationship between vertebral fracture burden
and height loss, determined by arm span  height. Arm
span is commonly used as a surrogate for maximum adult
height for individuals with spinal deformity, and the differ-
ence between arm span and height serves as a measure of
Vertebral Fractures and Lung Function 507height loss (14e16). We hypothesized that increased spine
fracture burden would be associated with decreased lung vol-
ume and height loss.
Materials and MethodsStudy DesignThis was a single-visit study at a single site. No investiga-
tional product was administered.PatientsSubjects were required to be women aged 70 yr and older
with osteoporosis and a history of at least 1 moderate or se-
vere vertebral fracture as determined by the investigator. Pa-
tients could not enter the study if they were active smokers
or had a history of moderate to severe asthma, COPD, pulmo-
nary fibrosis, emphysema, or other major lung disease. In
addition, study participants could not have taken inhaler-
delivered medications within the past 3 mo or have any severe
or chronically disabling conditions other than osteoporosis,
such as congestive heart failure. Patients were not selected
for this study based on their need for an inhaler.Fig. 1. Spinal deformity index is the sum of fracture grades
for T4 to L4 vertebrae. In the example shown, the patient has
three mild and one moderate vertebral fracture, for an SDI of
5. SDI, spinal deformity index.
Table 1
Patient Characteristics
Patient characteristics (N 5 41) Mean  SD Range
Spinal deformity index 7.4  5.6 2.0e22.0
Weight (kg) 59.2  8.7 40.1e77.8
BMI 24.1  3.1 15.1e29.7
Age (yr) 77.8  4.6 70.8e91.3
Abbr: BMI, body mass index; SD, standard deviation.Measures
Spinal Deformity Index
SDI was assessed as described (Fig. 1) (12,13,17). Briefly,
using lateral radiographs of the thoracic and lumbar spines,
the investigator visually scored each vertebra as semiquantita-
tive grade 0, 1, 2, or 3. Grade 0 indicates an unfractured
vertebra, grade 1 is mild compression (approx 20%e25%),
grade 2 is moderate compression (approx 25%e40%), and
grade 3 is severe compression (O40%). For each patient,
the number of mild, moderate, and severe vertebral fractures
was recorded. The SDI is the sum of the semiquantitative
scores of T4eL4 vertebrae. All patients had an SDI score
of 2 because study inclusion criteria required patients to
have at least 1 moderate vertebral fracture.
Height Loss
In this study, estimated height loss was calculated as the dif-
ference between arm span and height (14e16). Arm span was
measured to the nearest centimeter from the tips of the middle
fingers of maximally outstretched hands, with the patient
standing facing the wall. Height was measured using a Harpen-
den stadiometer (Holtain Ltd., Crosswell, Crymych, UK). Ac-
cording to a standardized protocol, patients were measured in
bare feet or thin socks, with their back against the wall-
mounted stadiometer, heels together, and head positioned in
the Frankfort horizontal plane. The patient was asked to
breathe in, and height was noted and recorded at peak inspira-
tion. Arm span and height measurements were taken one time.
Pulmonary Function
All pulmonary function measures were performed with pa-
tients seated upright. Patients were directed by trained staff on
proper use of the spirometer. Each measurement was repeated
3e5 times, with at least 1 min between inhalations. TheJournal of Clinical Densitometry: Assessment & Management of Muscuspirometry variables included peak inspiratory flow rate (L/
min), forced inspiratory vital capacity (L), average flow rate
of inspiration (L/min), forced inspiratory flow 25%e75%
(L/s), forced inspiratory flow 50% (L/s), forced inspiratory
volume in 1 s (L), and total inspiratory time (s). Expiratory
measures were not taken.Statistical AnalysisAll tests of treatment effects were conducted at a 2-sided
alpha level of 0.05 unless otherwise stated. Methods included
descriptive statistics, Pearson correlation and regression anal-
ysis, and individual patient listings.
Graphs were constructed to illustrate the relationship be-
tween SDI and other measured variables, and regression anal-
ysis was performed to quantify the relationships. Fittedloskeletal Health Volume 18, 2015
508 Krege et al.models with slope and intercept have been displayed along
with the scatter plots.
Analyses were performed on the average result of all trials
from each patient and also from each patient’s best effort. The
results were similar (data not shown), and this report includes
the findings from the best effort.
ResultsPatientsForty-one women aged 70e91 entered the study. Three pa-
tients were East Asian; the rest were Caucasians. Patient char-
acteristics are summarized in Table 1. All patients completed
the study.Fig. 2. Correlation between spinal deformity index, inspiratory
tween spinal deformity index (SDI) and (A) forced inspiratory vita
0.41, p 5 0.008), (C) estimated height loss (arm span  heigh
0.007), in 41 postmenopausal women with osteoporosis and verteb
vital capacity decreased by 1.62%. For each unit increase in SDI, i
represent the maximum value achieved from 3-5 efforts. R
2.62.042*SDI. The percentage is calculated as .042*100/2.62 5
is calculated as .10*100/4.30 5 2.39%. Estimated height loss (a
Journal of Clinical Densitometry: Assessment & Management of MuscuSDI Assessments
Vertebral Fracture Burden and Pulmonary Function
Vertebral fracture burden, as measured by SDI (Fig. 1),
negatively correlated with forced inspiratory vital capacity
(Fig. 2A) and inspiratory time (Fig. 2B). For each unit in-
crease in SDI, forced inspiratory vital capacity decreased by
1.62%, and inspiratory time decreased by 2.39%. There was
no correlation between SDI and measures of inspiratory
flow. A summary of the correlation between SDI and all pul-
monary function measures is provided in Table 2.
The impact of SDI on forced inspiratory vital capacity and
inspiratory time was further investigated by constructing a
model with age as an additional covariate; SDI remained ameasures, estimated height loss, and height. Correlation be-
l capacity (R 5 0.41, p 5 0.008), (B) inspiratory time (R 5
t) (R 5 0.44, p 5 0.004), and (D) height (R 5 0.42, p 5
ral fractures. For each unit increase in SDI, forced inspiratory
nspiratory time decreased by 2.39%. Respiratory function data
egression equations: Forced inspiratory vital capacity 5
1.62%. Inspiratory time 5 4.30.10*SDI. The percentage
rm span  height) 5 0.31 þ 0.53*SDI.
loskeletal Health Volume 18, 2015
Table 2
Summary of Correlations Between SDI and Other Study Measures in 41 Postmenopausal Women With Osteoporosis and
Vertebral Fractures
Measurement Mean  SD Range Correlation with SDI (R) Significance ( p)
Forced inspiratory vital capacity (L) 2.3  0.6 1.0e3.8 0.41 0.008
Inspiratory time (s) 3.5  1.4 1.4e5.8 0.41 0.008
Average flow rate of inspiration (L/min) 70.7  29.8 24.0e163.2 0.01 0.932
Forced inspiratory flow 25%e75% (L/s) 2.0  0.8 0.8e4.5 0.06 0.691
Forced inspiratory flow 50% (L/s) 2.1  0.9 0.8e4.8 0.07 0.657
Forced inspiratory volume, 1 s (L) 1.8  0.5 0.8e3.2 0.06 0.722
Peak inspiratory flow rate (L/min) 136.3  50.5 54.0e289.8 0.01 0.954
Height (cm) 156.6  6.5 141.9e169.8 0.42 0.007
Arm span (cm) 160.8  7.8 145.5e175.5 0.03 0.839
Estimated height loss (arm span  height) (cm) 4.3  6.8 16.7 to 15.4 0.44 0.004
Age (yr) 77.8  4.6 70.8e91.3 0.18 0.262
Note: Inspiratory variables are the maximum value of multiple tests.
Abbr: SD, standard deviation; SDI, spinal deformity index.
Vertebral Fractures and Lung Function 509statistically significant determinant of these parameters, and
the effect of each unit increase in SDI was quite similar to
the model that did not consider age (data not shown). Addi-
tionally, the impact of SDI on forced inspiratory vital capacity
and inspiratory time was investigated by excluding mild
vertebral fractures from the computation of SDI. This revised
SDI remained a statistically significant determinant of these
parameters, and the effect of each unit increase in SDI was
quite similar to the model that included the mild fractures
(data not shown).
Vertebral Fracture Burden and Height Loss
SDI positively correlated with estimated height loss (arm
span  height) and negatively correlated with height
(Fig. 2C and D; Table 2). For each unit increase in SDI, esti-
mated height loss (arm span  height) increased by 0.5 cm
and height decreased by 0.5 cm.SafetyThere were no adverse events, and clinical laboratory tests
were not performed.
Discussion
The purpose of this analysis was to assess the impact of
osteoporosis-related vertebral fracture burden on pulmonary
function. This study demonstrated that increased spine frac-
ture burden was associated with significant decreases in
forced inspiratory vital capacity (lung volume) and inspira-
tory time. Each unit increase in SDI was associated with a
1.62% reduction in forced inspiratory vital capacity and a
2.39% reduction in inspiratory time. The impact of spine frac-
ture burden to reduce inspiratory time likely is consistent with
a reduced lung volume. However, there was no significant
relationship between spine fracture burden and the measures
of flow rates. Thus, increased spine fracture burdenJournal of Clinical Densitometry: Assessment & Management of Muscusignificantly reduced lung volume but not flow, indicating
that spine fracture burden is linked with restrictive, but not
obstructive, lung disease.
The results suggest that a low burden of spine fractures
may have a small effect on lung volume and inspiratory
time. However, the patient’s respiratory status and the loca-
tion of the fracture are 2 important considerations. Even a
small reduction in lung volume in a patient with marginally
compensated respiratory status might be clinically relevant,
especially under conditions of respiratory stress (18). This
has been noted in a study of COPD patients (5) and a study
of women older than 65 yr, which found that patients with
vertebral fractures were 2e3 times more likely to die of
respiratory-related causes than those without vertebral frac-
tures (11). A larger burden of spine fractures may be associ-
ated with substantial reductions in volume.
Other studies have used expiratory measures to explore the
relationship between spinal deformity or vertebral fractures
and pulmonary function. Leech et al (15) estimated that for
every thoracic vertebral fracture, the forced vital capacity
declined approx 9%. The magnitude of difference between
these results and ours could be partially attributed to the dif-
ferences in expiratory vs inspiratory measurements. Two
other studies also showed that patients with osteoporosis
and vertebral fractures have reductions in expiratory vital ca-
pacity (18,19). In a 2007 review of 4 studies on the relation-
ship between osteoporotic kyphosis and pulmonary function,
including the aforementioned 2 studies, the authors concluded
that there was an association between osteoporosis-related
kyphosis, the number of vertebral fractures, and decreased vi-
tal capacity (20). More recently, an analysis of 282 men and
women with vertebral fractures led the authors to conclude
the relationship between vertebral fractures and pulmonary
function was not clinically relevant (21). Despite the overall
conclusion, however, the study revealed a significant differ-
ence in the ratio of forced expiratory volume in 1 s to forcedloskeletal Health Volume 18, 2015
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without vertebral fracture. Thus, some studies have suggested
a large impact of vertebral fractures on lung volume (15,18),
whereas 1 study has suggested little or no impact (21), and
the findings from our study suggest a moderate effect. Our
analysis is unique in its quantitative approach to the relation-
ship between vertebral fracture burden and pulmonary
function.
This analysis also quantified the relationship between
vertebral fracture burden and height loss defined as arm
span  height. This relationship was statistically significant,
with each unit increase in SDI conferring about 0.5 cm of
height loss. This finding suggests that the typical 2-cm
measured height loss threshold for defining height loss is un-
likely to detect a small change in spine fracture status (22).
The results of this study confirm and extend the findings of
several other studies (15,18,23).
As a post hoc analysis of a small number of patients, this
study has some limitations. Respiratory function analyses
typically assess expiration, whereas this study collected
inspiratory-based measurements. The study measured forced
inspiratory vital capacity as a measure of lung volume, but to-
tal lung capacity was not formally measured. Thus, although
unlikely, the measured reduction in forced inspiratory vital
capacity could be related to an increase in residual volume
rather than a decrease in total lung volume. The study
included only 41 patients at a single center and lacks longitu-
dinal data to confirm height loss prospectively. Women with
no or only mild fractures were not included in the study,
which may have limited our ability to fully assess the impact
of fractures. Single height and arm span measurements, as
well as single-read radiographs, are also study limitations.
The location of each vertebral fracture was not recorded, so
the study did not assess the impact of lumbar vs thoracic
vertebral fractures, although the location of the fracture likely
affects pulmonary function. Finally, no data were analyzed
with respect to patients’ history of glucocorticoid use,
although patients were excluded from the study if they had
used inhaler-delivered medications within the past 3 mo or
had significant pulmonary disorders. History of glucocorti-
coid use is an important issue, and inclusion of these patients
might have yielded different results.
In conclusion, this study quantified the relationship be-
tween vertebral fracture burden and pulmonary function
and estimated height loss. Vertebral fractures had statisti-
cally significant effects on lung volume, and these effects
may be clinically relevant in some patients. For example,
a patient with marginally compensated pulmonary function
taking glucocorticoids for lung disease who develops verte-
bral fractures might further compromise their pulmonary
function. Our study reinforces the adverse health conse-
quences of vertebral fractures. Technologies such as verte-
bral fracture assessment provide opportunities to identify
vertebral fractures at point of care. The data presented
will help radiologists and dual-energy X-ray absorptiometry
clinicians to better understand the clinical relevance of
vertebral fractures in their patients.Journal of Clinical Densitometry: Assessment & Management of MuscuAcknowledgments
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